BioXcel Therapeutics, Inc. (BTAI) Total liabilities 2022–2025
BioXcel Therapeutics, Inc. (BTAI) total liabilities at each fiscal year-end, per SEC filings.
$140.4MFY2025 · since FY2022: $129.1M → $140.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $140.4M | +6.8% |
| FY2024 | $131.4M | +0.9% |
| FY2023 | $130.2M | +0.9% |
| FY2022 | $129.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice